| Manijeh Kamyar, MD | |
|
5050 Ne Hoyt St Ste 230, Portland, OR 97213-2981 | |
| (503) 482-1800 | |
| (503) 482-1805 |
| Full Name | Manijeh Kamyar |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 5050 Ne Hoyt St Ste 230, Portland, Oregon |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215174651 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | MD193120 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iriye Medical Group Pllc | 2163415910 | 38 |
News Archive
Abide Therapeutics announced today that the Company has entered into a collaborative agreement with the University of Oxford and the Oxford University Hospitals NHS Trust to explore the therapeutic potential of serine hydrolases, one of the largest enzyme classes with validated but under explored class of drug targets.
Scientists at Barrow Neurological Institute have recently made discoveries about use of a new technology for imaging brain tumors in the operating room - a finding that could have important implications for identifying and locating invading cells at the edge of a brain tumor.
Ligand Pharmaceuticals Incorporated today announced that its previously disclosed 1-for-6 reverse stock split has become effective, and will be reflected in the share price beginning today.
Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO, the latest optimised transfection reagent in their product portfolio. FectoPRO has been designed for high yields in medium and large-scale production of proteins and antibodies in mammalian cells.
› Verified 6 days ago
| Entity Name | Iriye Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467496240 PECOS PAC ID: 2163415910 Enrollment ID: O20040406001830 |
News Archive
Abide Therapeutics announced today that the Company has entered into a collaborative agreement with the University of Oxford and the Oxford University Hospitals NHS Trust to explore the therapeutic potential of serine hydrolases, one of the largest enzyme classes with validated but under explored class of drug targets.
Scientists at Barrow Neurological Institute have recently made discoveries about use of a new technology for imaging brain tumors in the operating room - a finding that could have important implications for identifying and locating invading cells at the edge of a brain tumor.
Ligand Pharmaceuticals Incorporated today announced that its previously disclosed 1-for-6 reverse stock split has become effective, and will be reflected in the share price beginning today.
Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO, the latest optimised transfection reagent in their product portfolio. FectoPRO has been designed for high yields in medium and large-scale production of proteins and antibodies in mammalian cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Manijeh Kamyar, MD 7650 Sw Beveland Rd Ste 200, Portland, OR 97223-8692 Ph: (503) 601-3615 | Manijeh Kamyar, MD 5050 Ne Hoyt St Ste 230, Portland, OR 97213-2981 Ph: (503) 482-1800 |
News Archive
Abide Therapeutics announced today that the Company has entered into a collaborative agreement with the University of Oxford and the Oxford University Hospitals NHS Trust to explore the therapeutic potential of serine hydrolases, one of the largest enzyme classes with validated but under explored class of drug targets.
Scientists at Barrow Neurological Institute have recently made discoveries about use of a new technology for imaging brain tumors in the operating room - a finding that could have important implications for identifying and locating invading cells at the edge of a brain tumor.
Ligand Pharmaceuticals Incorporated today announced that its previously disclosed 1-for-6 reverse stock split has become effective, and will be reflected in the share price beginning today.
Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO, the latest optimised transfection reagent in their product portfolio. FectoPRO has been designed for high yields in medium and large-scale production of proteins and antibodies in mammalian cells.
› Verified 6 days ago
Dr. Rachel L Gutfreund, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10101 Se Main St Ste 3001, Portland, OR 97216 Phone: 503-261-4423 Fax: 503-261-4424 | |
John Gilbert Buckmaster, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4200 | |
Darlene J Dodson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9205 Sw Barnes Rd Fl 3, Portland, OR 97225 Phone: 503-216-3388 | |
Antonio E Frias, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-418-4200 Fax: 503-494-4473 | |
Sig-linda Jacobson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5006 Sw Martha St, Portland, OR 97221 Phone: 503-806-7854 | |
Laila Raad Sillay, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9555 Sw Barnes Rd Ste 360, Portland, OR 97225 Phone: 503-445-0590 | |
Edward Paul Kirk, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4500 |